Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2005

01-04-2005

Nitric Oxide Derived from Human Umbilical Vein Endothelial Cells Inhibits Transendothelial Migration of Neutrophils

Authors: Satoshi Oka, Masataka Sasada, Kokichi Yamamoto, Masaharu Nohgawa, Atsushi Takahashi, Kouhei Yamashita, Hiroko Yamada, Takashi Uchiyama

Published in: International Journal of Hematology | Issue 3/2005

Login to get access
Metadata
Title
Nitric Oxide Derived from Human Umbilical Vein Endothelial Cells Inhibits Transendothelial Migration of Neutrophils
Authors
Satoshi Oka
Masataka Sasada
Kokichi Yamamoto
Masaharu Nohgawa
Atsushi Takahashi
Kouhei Yamashita
Hiroko Yamada
Takashi Uchiyama
Publication date
01-04-2005
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2005
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04070

Other articles of this Issue 3/2005

International Journal of Hematology 3/2005 Go to the issue

OriginalPaper

Functional Diversity and Plasticity of Human Dendritic Cell Subsets

Review Article

In Vivo Platelet Production from Mature Megakaryocytes: Does Platelet Release Occur via Proplatelets?

OriginalPaper

Antigen Recognition and Presentation by Dendritic Cells

OriginalPaper

Dendritic Cells: Sentinels of Immunity and Tolerance

OriginalPaper

Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin’s Lymphoma

OriginalPaper

Influential Factors for the Collection of Peripheral Blood Stem Cells and Engraftment in Acute Myeloid Leukemia Patients in First Complete Remission
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits